Menthol

Menthol

SCHEMBL8187948

CC1CCC(C(C)C)C(O)C1.CCCCC(=O)Oc1ccccc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of Menthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TRPM8 known ✓ Q7Z2W7 3/20 0.47
TRPA1 known ✓ O75762 2/20 0.47
TRPV1 Q8NER1 6/20 0.44
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
RECQL P46063 1/20 0.43
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
KCNA5 P22460 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Menthol SCHEMBL27888021 0.79 TRPM8 (0.62) TRPM8TRPA1KMT2AMEN1ALDH1A1
Diphenylether SCHEMBL28381201 0.78 TRPM8 (0.64) TRPM8TRPA1TRPV1KMT2AKDM4E
SCHEMBL2032746 0.77 TRPV1 (0.50) TRPM8TRPV1ALDH1A1HPGDKCNA5
SCHEMBL643462 0.76 KMT2A (0.63) KMT2AKDM4EMEN1RECQLALDH1A1
Menthol SCHEMBL28980170 0.76 TRPA1 (0.60) TRPM8TRPA1KMT2AMEN1ALDH1A1
Menthol SCHEMBL27673361 0.75 TRPM8 (0.78) TRPM8TRPA1TRPV1ALDH1A1KCNA5
Hydrochloric Acid SCHEMBL27525464 0.75 KMT2A (0.61) KMT2AKDM4EMEN1RECQLALDH1A1
Bromide SCHEMBL28850559 0.75 KMT2A (0.61) KMT2AKDM4EMEN1RECQLALDH1A1
Palmitic Acid SCHEMBL28857858 0.74 TRPA1 (0.58) TRPM8TRPA1KMT2AMEN1ALDH1A1
Dodecanoate SCHEMBL18247782 0.74 TRPA1 (0.58) TRPM8TRPA1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6011001-A Method of protein therapy by orally administering crosslinked protein crystals VERTEX PHARMACEUTICALS, INC. (US) 2000-01-04 US disclosed
US-6004768-A Biosensors, extracorporeal devices and methods for detecting substances using crosslinked protein crystals VERTEX PHARMACEUTICALS, INC. (US) 1999-12-21 US disclosed
US-5976529-A Methods of enzyme therapy by orally administering crosslinked enzyme crystals VERTEX PHARMACEUTICALS, INC. (US) 1999-11-02 US disclosed
US-5849296-A Crosslinked protein crystals VERTEX PHARMACEUTICALS, INC. (US) 1998-12-15 US disclosed
US-5618710-A RESISTANCE TO EXOGENOUS PROTEOLYSIS VERTEX PHARMACEUTICALS, INC. (US) 1997-04-08 US disclosed